CVS Health stock: buy or sell?

CVS stock price: $75.35 0.33% At close on November 19th, 2019

Updated on:
November 19th, 2019

3

Shares of CVS Health closed today at $75.35 and stayed stable a slightly fine 0.33%. Counting Tuesday, it's been 5 green sessions in a row, soaring $3.00 or 4.18%.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail\u002FLTC segments.

Should I buy CVS Health stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading strategy that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with CVS Health stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean CVS will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is CVS Health stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we collected 15 ratings published for CVS stock in the last month.

The general sentiment of these ratings is bullish for CVS stock, with 9 positive ratings.
Is CVS a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-27Royal Bank of Canadan/aOutperform
2019-9-26Morgan Stanleyn/aOverweight
2019-9-12Deutsche Bankn/aBuy
2019-9-12Bank of American/aBuy
2019-8-8Citigroupn/aBuy
2019-8-27Cowenn/aOutperform
2019-5-2UBS GroupBuySell
2019-5-2UBS GroupSellSell
2019-5-2Citigroupn/aBuy
2019-4-29Morgan StanleyOverweightOverweight
2019-4-29Credit Suisse GroupOutperformNeutral
2019-4-18Raymond JamesStrong-BuyStrong-Buy
2019-4-15OppenheimerOutperformMarket Perform
2019-4-10SunTrust Banksn/an/a
2019-4-10Bank of American/aBuy

CVS Health stock analysis

Daily outlook

CVS Health shares stayed constant 0.33% to $75.35 today.

CVS Health ended today at $75.35 and stayed stable a slightly fine 0.33%. Since SMA100d and SMA200d crossed up on October/14, CVS price climbed $12.88 per share (20.62%). CVS shows a strong short term uptrend with several rising tops and rising bottoms. Since its last bottom on November 12th, CVS climbed unceasignly breaking out above its last top at 72.98.

CVS stock chart (daily)

Weekly outlook

CVS Health shares raised 1.43% this week, ending at $75.35. This week was the 4th green week in a row. Early November CVS boosted an extraordinary 7.22% in just one week.

Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $64.76 resistance. Since SMA20d and SMA40w crossed up early October, CVS price climbed $13.58 per share (21.98%). Since price and SMA40w lines crossed up by mid August, CVS climbed $16.51 (28.06%).

CVS stock chart (weekly)

CVS Health stock price history

CVS Health stock historical price chart

CVS stock reached 52-week highs on November at $78.95, and all-time highs 2015-07-29 with a price of 101.95.

CVS Health stock price target is $74.50

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we found 12 price forecasts for CVS Health stock:
CVS stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-26Morgan StanleyRaises Target$74.00$77.004.1%
2019-9-12Deutsche BankInitiatesn/a$91.00-
2019-9-12Bank of AmericaRaises Target$72.00$75.004.2%
2019-8-8CitigroupReiterates$68.00$72.005.9%
2019-8-27CowenReiterates$69.00$76.0010.1%
2019-5-2UBS GroupRaises Target$67.00$74.0010.4%
2019-5-2UBS GroupLowers Target$74.00$67.00-9.5%
2019-5-2CitigroupSet Price Targetn/a$74.00-
2019-4-29Morgan StanleyLowers Target$92.00$74.00-19.6%
2019-4-18Raymond JamesLowers Target$90.00$75.00-16.7%
2019-4-10SunTrust BanksLowers Target$85.00$65.00-23.5%
2019-4-10Bank of AmericaLowers Target$82.00$74.00-9.8%
(in average)$77.30$74.50-4.0%
The price prediction for CVS Health stock is $74.50, moving in a range between $91.00 and $65.00. In average, analysts' outlook on CVS price target is negative, reducing the target by a -4.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

CVS Health reported slightly good results for 2018-Q4 on February. CVS Health gained Earnings per Share (EPS) by 3.40%, beating experts of $2.07. CVS Health posted $2.14.
CVS earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a1.07n/a
2017-Q32017-11-061.491.50.7%
2017-Q42018-02-081.881.922.1%
2018-Q12018-05-021.391.486.5%
2018-Q22018-08-081.611.695.0%
2018-Q32018-11-061.711.731.2%
2018-Q42019-02-202.072.143.4%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

Compared to 2017, last anual turnover report draw a nice increase of 5.30% to $194,579.00 M USD. However, its profit margin (compared to sales) declined to -0.31%, that is $-594.00 million.

CVS annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$126,760 M-$4,600 M3.6%-
2014$139,367 M9.95%$4,644 M3.3%0.96%
2015$153,290 M9.99%$5,237 M3.4%12.77%
2016$177,526 M15.81%$5,317 M3.0%1.53%
2017$184,786 M4.09%$6,622 M3.6%24.54%
2018$194,579 M5.30%$-594.00 M-0.3%-108.97%

Quarterly financial results

CVS Health posted $54,909.00 M in sales for 2018-Q4, a 16.16% up compared to previous quarter. Reported quarter income marked $-419.00 million with a profit margin of -0.76%. Profit margin decreased a -3.70% compared to previous quarter when profit margin was 2.94%. When comparing revenues to same quarter last year, CVS Health sales marked an astounding gain and skyrocketed a 13.48%. Looking back to recent quarterly results, CVS Health posted 3 positive quarters in a row.
CVS quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$45,690 M-$1,090.00 M2.4%-
2017-Q3$46,181 M1.07%$1,285.00 M2.8%17.89%
2017-Q4$48,385 M4.77%$3,287.00 M6.8%155.80%
2018-Q1$45,693 M-5.56%$998.00 M2.2%-69.64%
2018-Q2$46,708 M2.22%$-2,563.00 M-5.5%-356.81%
2018-Q3$47,269 M1.20%$1,390.00 M2.9%-154.23%
2018-Q4$54,909 M16.16%$-419.00 M-0.8%-130.14%
2019-Q1$61,646 M12.27%$1,421.00 M2.3%-439.14%

CVS Health ownership

When you are planning to invest in a stock, it's worth to overview its ownership structure.

CVS Health shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.24% of all shares.

Bearish positions for CVS stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related stocks:

CVSPETSWBA
Market cap$98.0 B$457.3 M$55.3 B
Total shares1,300.0 M20.2 M892.5 M
Float shares1,300.0 M17.2 M743.2 M
  - Institutional holdings (%)83.8%104.8%66.4%
  - Insider holdings (%)0.2%3.8%16.1%
Shares in short selling0.0%0.0%0.0%

CVS Health summary

Tuesday, November 19th, 2019
Open$75.28
Close$75.35
Day range$74.46 - $75.47
Previous close$75.10
Session gain0.33%
Average true range$1.41
50d mov avg$65.56
100d mov avg$61.55
200d mov avg$58.10
Daily patternlb03c
Weekly pattern lb02c

CVS Health performance

To measure stock performance is always good to compare with competitors or related stocks. For CVS Health, the benchmark is made against PetMed Express and Walgreens Boots Alliance.
Stock3m6m12m
CVSCVS Health26.02%44.35%3.65%
PETSPetMed Express48.36%27.86%-4.02%
WBAWalgreens Boots A...26.51%21.64%-20.93%

CVS Health competitors

Creating a list of competitors for CVS Health it's not an easy task. We selected 2 public companies that are related to and can be considered as competitors of CVS Health:

Latest CVS Health stock news